retatrutide mechanism gip glp-1 glucagon triple agonist Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight retatrutide mechanism triple agonist glp-1

This expertise proves particularly valuable for patients with diabetes, thyroid disorders, or other endocrine conditions

Newer incretin-based medications like semaglutide and tirzepatide have changed obesity treatment by producing substantial weight loss, but their effects on neuropsychiatric health remain uncertain in routine clinical practice

Any decision to initiate GLP-1 therapy should involve shared decision-making that weighs individual patient factors, comorbidities, and realistic expectations about potential cognitive benefits

If dizziness persists despite appropriate management strategies, further investigation may be warranted to exclude other causes unrelated to the medication itself

Doing so will give your skin time to heal in between injections

Targeted, science-backed supplementation designed to support muscle, metabolism, and long-term metabolic health